Glaxosmithkline reported GBP20.77B in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US USD 22.19B 1.88B
AstraZeneca AZN:LN USD 22.59B 2.37B
Aurora Cannabis Inc ACB:CN CAD 542.79M 139.04M
Canopy Growth Corp WEED:CN CAD 1.17B 365.26M
Catalent CTLT:US USD 2.92B 220M
Corcept Therapeutics CORT:US USD 499.25M 46.85M
Drreddys Laboratories RDY:US INR 194.49B 18.88B
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Glaxosmithkline GSK:US GBP 20.77B 520M
Horizon Pharma HZNP:US USD 3.65B 240.83M
Lannett LCI:US USD 250.53M 14.13M
Novartis NOVN:VX USD 36.91B 44M
Pacira Pharmaceuticals PCRX:US USD 498.33M 35.08M
Perrigo Ordinary Shares PRGO:US USD 2.72B 136.6M
Phibro Animal Health PAHC:US USD 581.69M 11.61M
Prestige Brands PBH:US USD 408.85M 72.19M
Roche Holding ROG:VX 33.82B 3.5B
Supernus Pharmaceuticals SUPN:US USD 734.15M 70.26M
Takeda 4502:JP JPY 2.6T 149.67B
Teva Pharmaceutical TEVA:IT USD 12.05B 598M
Valeant Pharmaceuticals VRX:CN USD 4.25B 237M
Zoetis ZTS:US USD 7.51B 955M